MARKET

ALVO

ALVO

Alvotech
NASDAQ
9.55
-0.81
-7.82%
After Hours: 9.55 0 0.00% 16:20 03/28 EDT
OPEN
10.25
PREV CLOSE
10.36
HIGH
10.25
LOW
9.55
VOLUME
130.19K
TURNOVER
--
52 WEEK HIGH
14.76
52 WEEK LOW
9.15
MARKET CAP
2.88B
P/E (TTM)
-5.0353
1D
5D
1M
3M
1Y
5Y
1D
Oversold Conditions For Alvotech (ALVO)
NASDAQ · 1d ago
Alvotech (ALVO) Gets a Buy from Northland Securities
TipRanks · 1d ago
Alvotech Achieves Record Revenue Growth in 2024
TipRanks · 2d ago
Alvotech reports FY24 EPS (87c), one estimate (55c)
TipRanks · 2d ago
Alvotech sees FY25 revenue $570M-$670M, consensus $629.15M
TipRanks · 2d ago
Alvotech Appoints New Chief Strategy Officer to Strengthen Market Position
TipRanks · 2d ago
Alvotech Achieves Record 2024 Financial Results and Expands Biosimilar Pipeline
TipRanks · 2d ago
Alvotech FY 2024 GAAP EPS $(0.87) Misses $(0.55) Estimate, Sales $492.00M Beat $455.53M Estimate
Benzinga · 2d ago
More
About ALVO
More
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.
Recently
Symbol
Price
%Change

Webull offers Alvotech SA stock information, including NASDAQ: ALVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVO stock methods without spending real money on the virtual paper trading platform.